VIDA is a clinical imaging intelligence company, accelerating the approval and adoption of life-saving therapies to patients through its AI-powered digital biomarker solution. With best-of-breed imaging biomarkers and a modern approach to trial imaging management, the VIDA Intelligence Platform is helping biopharma sponsors leverage the power of quantitative imaging at scale.
| Website | https://vidalung.ai |
| Revenue | $21 million |
| Employees | 1,234 (73 on RocketReach) |
| Founded | 2004 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Digital Biomarkers, Imaging Biomarkers, Medical Imaging, Ai Medical Imaging, Ai Diagnostics, Ai Healthcare, Precision Medicine, Healthcare Ai, Deep Learning, Drug Development, Biomarker Discovery, Clinical Trials, Medical Technology, Clinical Decision Support, Therapeutics, Life Sciences, Data Analytics, Patient Care |
| Competitors | IBM, Tempus Labs, Inc., Flatiron Health, GRAIL, Freenome, PathAI, Perspectum Diagnostics Ltd, CureMetrix, Zebra Medical Vision Ltd, OncoOne +31 more (view full list) |
Looking for a particular VIDA employee's phone or email?
The VIDA annual revenue was $21 million in 2026.
Marty Henehan is the Vice President of Business Development of VIDA.
73 people are employed at VIDA.